DrugDashboards

Ketorolac Tromethamine

Ketorolac Tromethamine · KETOROLAC TROMETHAMINE 15 mg/mL · Injection, Solution · Intramuscular; Intravenous · Cardinal Health 107, LLC

NDC 55154-9366-05 · 5 VIAL, SINGLE-USE in 1 BAG / 1 mL in 1 VIAL, SINGLE-USE · ANDA · View full market →

The short version

20 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for ketorolac tromethamine (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $22.07 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA075784
TE code
AP
Approval date
Jan 11, 2002
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)Jun 6, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)Jun 6, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)Jun 6, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)Jun 6, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)Mar 26, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Mar 26, 2018
    Delay in shipping of the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)Mar 26, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Mar 26, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Mar 26, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)Mar 26, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Mar 23, 2018
    Demand increase for the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Mar 23, 2018
    Demand increase for the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)Mar 23, 2018
    Delay in shipping of the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)Mar 23, 2018
    Delay in shipping of the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ketorolac Tromethamine (Injection, Solution)

LabelerStrengthFirst seenLast seen
Advanced Rx of Tennessee, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Civica, Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Fosun Pharma Usa IncKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Gland Pharma LimitedKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
ProPharma DistributionKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.KETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Direct_rxKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Eugia US LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Fosun Pharma Usa IncKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.KETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Hospira, Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Proficient Rx LPKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ketorolac Tromethamine — NDC 55154-9366-05," retrieved September 3, 2026, https://drugdashboards.com/drug/55154936605.

Free to cite with attribution — see how the data is put together.